Form 4 for CGEN COMPUGEN LTD
Accepted 2026-07-30 16:06:41 ET · period of report 2026-07-29 · accession 0001178913-26-003717 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-30 16:06 | 2026-07-29 | CGEN | Kredo Russo Sharon | SVP, Research, Discovery | A - Grant | $0.00 | +18.0K | 37.5K | +92% | $0 |
| D | 2026-07-30 16:06 | 2026-07-29 | CGEN | Kredo Russo Sharon | SVP, Research, Discovery | A - Grant | $0.00 | +24.0K | 24.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-29 | A | A | 18,000 | $0.00 | 37,500 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |
| 2 | Derivative | Share Option (right to buy) | 2026-07-29 | A | A | 24,000 | $0.00 | 24,000 | D | $2.26 · — to 2036-07-29 | 24,000 Ordinary Shares | (F2) This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |